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Activating the Innate Immune Response by Utilizing Macrophages as a
Defense for Immunosuppressed Individuals and COVID-19
Ashley Coddington, Christina Amoruso, and Emma Rogers
BIOL 488: Senior Capstone, Longwood University

Proposal
• We propose to the Virginia House of Delegates for their public support in spreading awareness for the need for an alternative
treatment option against COVID-19 for immunosuppressed individuals.

Background

Objectives

• COVID-19 is a virus that attacks the respiratory system and
causes acute respiratory syndrome (SARS-CoV-2) (Kamenidou
et al. 2020).
• SARS-CoV-2 contains spike proteins on the outer edges that
are transmitted by respiratory droplets and enter healthy cells
via binding to angiotensin-converting enzyme 2 (ACE2)
receptors (Huang, Y. et al. 2020).

• Problem: Immunosuppressed individual’s adaptive immune
response is not effectively activating to the COVID-19 vaccine.
• Audience: Virginia House of Delegates
• Thesis: The activation of the innate immune response by
utilizing Interferon-Gamma to activate macrophages will provide
for immunosuppressed individuals an additional treatment
option for COVID-19.

Methods
• A few of the cells that are in the innate immune response are
macrophages, mast cells, neutrophils, dendritic cells, natural
Figure 1. Total cases, hospitalizations, and death from COVID-19 in Virginia (CDC 2021).
killers and basophils. These cells are responsible for the
• The current treatment research for COVID-19 has been focused
immune response to a pathogen (Espíndola et al. 2016).
on creating a long-term memory response, via targeting the
• We believe activating macrophages would be the most effective
body’s adaptive immunity. (Fig. 2)
because it has shown to be more effective in resisting infections
• Prevention of infection by using targeted proteins, receptors and
such as HIV-1 than CD4+ T-cells (Koppensteiner et al. 2012)
enzymes that are a part of the T cell response in the adaptive
• Macrophages have the ability to kill invading and infectious
immune system (Wondmkun & Ousman 2020).
cells.

Figure 2. How the mRNA COVID-19 vaccine works (Miller 2020).

• The two types of immune responses that fight off a pathogen are
the innate immune response and the adaptive immune
response. (Fig. 3)

Innate Vs. Adaptive Immune System
Figure 3. Macrophage function (Learning).
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Table 1. Comparison of the innate versus adaptive immune system.

• The current vaccine research being done is focusing on
targeting T cell responses to induce an adaptive immune
response (Nelde et al. 2021).
• Immunosuppressed individuals are not responsive to the
COVID-19 vaccine due to a T-cell deficiency, therefore, they
need another treatment option (Boyarsky et al. 2021).

• Cytokines like interferon-gamma (IFN-y) can activate
macrophages (Activated Macrophages).
• IFN-y should be injected into the bloodstream
immunosuppressed individuals to activate macrophages.
○ it is not effective when ingested orally (Bennett et al. 2013).

Conclusion
• With funding for research we will be able to execute a clinical
trial and research to determine if this is an alternative treatment
for immunocompromised individuals.
• Expected results:
○ By activating macrophages with IFN-y, immunocompromised
individuals should be more protected from
transmitting COVID-19 or if they do have
milder symptoms lessening their risk of
death (Schijns & Lavelle 2020).
• Scan the QR code to the right for references.

